Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Lung Cancer Therapy Annual 7 -

Lung Cancer Therapy Annual 7

Rolf A. Stahel (Herausgeber)

Buch | Hardcover
184 Seiten
2012 | 7th edition
CRC Press (Verlag)
978-1-84184-865-5 (ISBN)
CHF 189,95 inkl. MwSt
  • Versand in 10-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Highly Commended, BMA Medical Book Awards 2013

Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of an acclaimed reference briefs the oncology community with a review of the recent literature, emphasizing the most significant therapeutic advances. The expert contributions of Lung Cancer Therapy Annual 7 offer an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

New to the seventh edition are four new chapters on the treatment of non-small cell lung cancer (NSCLC) and a new chapter on thymoma. Additional topics include:






Oncogenic driver mutations



First line therapy of advanced non-small cell lung cancer without activating EGFR mutation



Second line therapy of non-small cell lung cancer



Adjunct and neoadjunct therapy of non-small cell lung cancer



Advances in surgery of lung cancer; advances in radiotherapy of lung cancer



Mesothelioma



Thymic tumors

Rolf A. Stahel, M.D. is head of the Center for Lung and Thoracic Oncology and Senior Staff Physician at the Clinic of Oncology, University Hospital of Zürich as well as Titular Professor of Medicine at the University of Zürich, Switzerland. He is certified in Internal Medicine and Medical Oncology by both the American and Swiss Board. His major interest is thoracic oncology, including multidisciplinary treatment approaches, translational research, and targeted therapy.

1. Epidemiology
2. Prevention, early detection, and screening
3. Staging
4. Histopathology and molecular pathology
5. Oncogenic driver mutations
6. First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
7. First line therapy of advanced non-small cell lung cancer with activating EGFR mutation
8. Second line therapy of non-small cell lung cancer
9. Adjuvant and neoadjuvant therapy of non-small cell lung cancer
10. Advances in surgery of lung cancer
11. Advances in radiotherapy of lung cancer
12. Small cell lung cancer
13. Mesothelioma
14. Thymoma

Erscheint lt. Verlag 13.8.2012
Zusatzinfo 37 Tables, black and white; 15 Line drawings, black and white; 7 Halftones, color; 11 Halftones, black and white
Verlagsort London
Sprache englisch
Maße 174 x 246 mm
Gewicht 570 g
Themenwelt Medizinische Fachgebiete Innere Medizin Pneumologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-84184-865-4 / 1841848654
ISBN-13 978-1-84184-865-5 / 9781841848655
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Atemphysiologie und Beatmungstechnik

von Wolfgang Oczenski

Buch (2023)
Thieme (Verlag)
CHF 153,95
International Trauma Life Support (ITLS)

von John E. Campbell; Roy L. Alson; Eva Molter; Klaus Meyer …

Buch | Softcover (2024)
Hogrefe AG (Verlag)
CHF 91,00